(Press-News.org) Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published online in BMJ Evidence Based Medicine.
Even light drinking—generally thought to be protective, based on observational studies—is unlikely to lower the risk, which rises in tandem with the quantity of alcohol consumed, the research indicates.
Current thinking suggests that there might be an ‘optimal dose’ of alcohol for brain health, but most of these studies have focused on older people and/or didn’t differentiate between former and lifelong non-drinkers, complicating efforts to infer causality, note the researchers.
To try and circumnavigate these issues and strengthen the evidence base, the researchers drew on observational data and genetic methods (Mendelian randomisation) from two large biological databanks for the entire ‘dose’ range of alcohol consumption.
These were the US Million Veteran Program (MVP), which includes people of European, African, and Latin American ancestry, and the UK Biobank (UKB), which includes people of predominantly European ancestry.
Participants who were aged 56–72 at baseline, were monitored from recruitment until their first dementia diagnosis, death, or the date of last follow-up (December 2019 for MVP and January 2022 for UKB), whichever came first. The average monitoring period was 4 years for the US group, and 12 for the UK group.
Alcohol consumption was derived from questionnaire responses—over 90% of participants said they drank alcohol—and the Alcohol Use Disorders Identification Test (AUDIT-C) clinical screening tool. This screens for hazardous drinking patterns, including the frequency of binge drinking (6 or more drinks at a time).
In all, 559,559 participants from both groups were included in observational analyses, 14,540 of whom developed dementia of any type during the monitoring period:10,564 in the US group; and 3976 in the UK group. And 48,034 died: 28,738 in the US group and 19,296 in the UK group.
Observational analyses revealed U-shaped associations between alcohol and dementia risk: compared with light drinkers (fewer than 7 drinks a week) a 41% higher risk was observed among non-drinkers and heavy drinkers consuming 40 or more drinks a week, rising to a 51% higher risk among those who were alcohol dependent.
Mendelian randomisation genetic analyses drew on key data from multiple large individual genome-wide association studies (GWAS) of dementia, involving a total of 2.4 million participants to ascertain lifetime (rather than current) genetically predicted risks.
Mendelian randomisation leverages genetic data, minimising the impact of other potentially influential factors, to estimate causal effects: genomic risk for a trait (in this case, alcohol consumption) essentially stands in for the trait itself.
Three genetic measures related to alcohol use were used as different exposures, to study the impact on dementia risk of alcohol quantity, as well as problematic and dependent drinking.
These exposures were: self-reported weekly drinks (641 independent genetic variants); problematic ‘risky’ drinking (80 genetic variants); and alcohol dependency (66 genetic variants).
Higher genetic risk for all 3 exposure levels was associated with an increased risk of dementia, with a linear increase in dementia risk the higher the alcohol consumption.
For example, an extra 1-3 drinks a week was associated with a 15% higher risk. And a doubling in the genetic risk of alcohol dependency was associated with a 16% increase in dementia risk.
But no U-shaped association was found between alcohol intake and dementia, and no protective effects of low levels of alcohol intake were observed. Instead, dementia risk steadily increased with more genetically predicted drinking.
What’s more, those who went on to develop dementia typically drank less over time in the years preceding their diagnosis, suggesting that reverse causation—whereby early cognitive decline leads to reduced alcohol consumption—underlies the supposed protective effects of alcohol found in previous observational studies, say the researchers.
They acknowledge that a principal limitation of their findings is that the strongest statistical associations were found in people of European ancestry, because of the numbers of participants of this ethnic heritage studied. Mendelian randomisation also relies on assumptions that can’t be verified, they add.
Nevertheless, they suggest that their findings “challenge the notion that low levels of alcohol are neuroprotective.”
And they conclude: “Our study findings support a detrimental effect of all types of alcohol consumption on dementia risk, with no evidence supporting the previously suggested protective effect of moderate drinking.
“The pattern of reduced alcohol use before dementia diagnosis observed in our study underscores the complexity of inferring causality from observational data, especially in ageing populations.
“Our findings highlight the importance of considering reverse causation and residual confounding in studies of alcohol and dementia, and they suggest that reducing alcohol consumption may be an important strategy for dementia prevention.”
END
Drinking any amount of alcohol likely increases dementia risk
Even light drinking is unlikely to be protective; risk rises in tandem with quantity consumed
2025-09-23
ELSE PRESS RELEASES FROM THIS DATE:
BMJ Group retracts trial on apple cider vinegar and weight loss
2025-09-23
BMJ Group has retracted research suggesting that small daily quantities of apple cider vinegar might help people who are overweight or obese to lose weight.
The small clinical trial was published in the open access journal BMJ Nutrition, Prevention & Health in March 2024 and its findings press released. The study findings generated widespread international attention at the time, and continue to be frequently referred to in media coverage.
The retraction was prompted by concerns raised about the quality of the work, ...
Significant rise in use of low/alcohol-free drinks among ‘risky’ UK drinkers in past 5 years
2025-09-23
There’s been a significant rise in the use of low and alcohol-free drinks to curb alcohol intake among ‘risky drinkers’ over the past 5 years in England, Wales, and Scotland, finds research published in the open access journal BMJ Public Health.
The proportion of those using them to make serious attempts to cut down their alcohol intake rose from 35% in 2020 to 44% in 2024, while those using them in any attempt to cut down increased from 26% to 39%.
The trends were especially noticeable ...
Regular exercise ‘rewires’ heart-control nerves differently on left and right side, study finds
2025-09-23
Frequent exercise doesn’t just strengthen the heart – it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.
The study, led by the University of Bristol (UK), shows for the first time that moderate aerobic training reshapes nerves that drive the heart, and affects them on each side of the heart differently. The research is published in the journal Autonomic Neuroscience today (Wednesday, 24 September).
Findings ...
Centenary of the birth of IVF pioneer Sir Robert Edwards
2025-09-23
Saturday 27th September marks the centenary of the birth of Sir Robert Edwards, who with colleagues Patrick Steptoe and Jean Purdy oversaw the conception and birth of the world’s first IVF baby in 1978.(1) It was a breakthrough in reproductive medicine which would bring immeasurable benefits to people with infertility and whose demographic importance today is greater than ever.
Now, from various reports published by this journal, we can confidently say that the global impact of IVF continues to grow in terms of children conceived and the extent of its use. There are few causes of infertility which today are not amenable to treatment while ...
New multi-registry study highlights ocrelizumab’s superior relapse control in multiple sclerosis
2025-09-23
(Barcelona, Spain, Wednesday, 24 September 2025) New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.1
Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, was evaluated using real-world data from three large MS registries: MSBase, OFSEP, and the Danish MS Registry. The analysis compared ocrelizumab-treated patients ...
Wonhwa Cho to receive Biophysical Society’s 2026 Award in the Biophysics of Health and Disease
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Wonhwa Cho, of the University of Illinois Chicago, USA, has been named the recipient of the 2026 BPS Award in the Biophysics of Health and Disease. Cho will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Cho will be recognized for mechanistic elucidation of lipid-protein interactions foundational to lipid-targeted drug discovery.
“Wonhwa has pioneered new and innovative experimental approaches to overcome obstacles ...
Future generations: NSF-funded project explores how nanoplastics are transmitted to offspring
2025-09-23
You can’t see nanoplastics with the naked eye, but they’re everywhere — including your body.
Tinier than the better-known microplastics, these plastic particles range from one nanometer to one micrometer in size; a human hair, by comparison, is about 100 micrometers thick.
“Nanoplastics are present in drinking water, food and the air, and have been detected in both tap water and bottled water,” explained Binghamton University Assistant Professor of Chemistry Huiyuan Guo. “They are widely detected in the environment.”
Guo and Associate Professor of Biological Sciences ...
Erdinc Sezgin to receive 2026 Early Independent Career Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Erdinc Sezgin, of SciLifeLab, Karolinska Institutet, Sweden, has been named the recipient of the 2026 Early Independent Career Award. Sezgin will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Sezgin will be recognized for combining chemistry, physics, biology and computer science to gain fundamental and translational insights into how the biophysics of cells affect health and disease.
“I am delighted that Erdinc ...
Charles L. Brooks III to receive 2026 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Charles L. Brooks III, of the University of Michigan, USA, has been named the recipient of the 2026 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award. Brooks will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Brooks will be recognized for his pioneering work in protein folding, free energy methods and service to the field of biophysics.
“Charles’ work leads the field not only in methodological ...
Jie Xiao to receive 2026 Carolyn Cohen Innovation Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Jie Xiao, of the Johns Hopkins School of Medicine, USA, will receive the 2026 Carolyn Cohen Innovation Award. Xiao will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Xiao will be recognized for her pioneering work in developing single-molecule imaging and analysis approaches to investigate the molecular and cellular mechanisms of bacterial cell division and transcription.
“Jie’s ...
LAST 30 PRESS RELEASES:
National Multiple Sclerosis Society awards Dr. Manuel A. Friese the 2025 Barancik Prize for Innovation in MS Research
PBM profits obscured by mergers and accounting practices, USC Schaeffer white paper shows
Breath carries clues to gut microbiome health
New study links altered cellular states to brain structure
Palaeontology: Ancient giant kangaroos could hop to it when they needed to
Decoded: How cancer cells protect themselves from the immune system
ISSCR develops roadmap to accelerate pluripotent stem cell-derived therapies to patients
New study shows gut microbiota directly regulates intestinal stem cell aging
Leading cancer deaths in people younger than 50 years
Rural hospital bypass by patients with commercial health insurance
Jumping giants: Fossils show giant prehistoric kangaroos could still hop
Missing Medicare data alters hospital penalties, study finds
Experimental therapy targets cancer’s bodyguards, turning foe to friend to eliminate tumors
Discovery illuminates how inflammatory bowel disease promotes colorectal cancer
Quality and quantity? The clinical significance of myosteatosis in various liver diseases
Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)
Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo
New imaging technology detects early signs of heart disease through the skin
Resurrected ancient enzyme offers new window into early Earth and the search for life beyond it
People with obesity may have a higher risk of dementia
Insilico Medicine launches science MMAI gym to train frontier LLMs into pharmaceutical-grade scientific engines
5 pre-conference symposia scheduled ahead of International Stroke Conference 2026
To explain or not? Need for AI transparency depends on user expectation
Global prevalence, temporal trends, and associated mortality of bacterial infections in patients with liver cirrhosis
Scientists discover why some Central Pacific El Niños die quickly while others linger for years
CNU research explains how boosting consumer trust unlocks the $4 billion market for retired EV batteries
Reimagining proprioception: when biology meets technology
Chungnam National University study finds climate adaptation can ease migration pressures in Africa
A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome
Brain network disorders study provides insights into the role of molecular chaperones in neurodegenerative diseases
[Press-News.org] Drinking any amount of alcohol likely increases dementia riskEven light drinking is unlikely to be protective; risk rises in tandem with quantity consumed